Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: A substudy of the Avastin in Lung trial

• Main Authors: Mok T.S.K., Hsia T.-C., Tsai C.-M., Tsang K., Chang G.-C., Chang J.W.-C., Thitiya S., Sriuranpong V., Thongprasert S., Chua D.T., Moore N., Manegold C.
• Format: Article
• Language: English
• Published: 2014
• Online Access: http://www.scopus.com/inward/record.url?eid=2-s2.0-79956133688&partnerID=40&md5=cd88f31639aaa798db85abb5e0611d75; http://cmuir.cmu.ac.th/handle/6653943832/3757
• Institution: Chiang Mai University

Aim: The phase III AVAiL study evaluated the efficacy and safety of the anti-vascular epidermal growth factor agent bevacizumab combined with platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer (NSCLC). We report the results of a preplanned analys...